Document is current
Any future updates will be listed below
-
Authors
Sarraju, Ashish
Seninger, Clark
Parameswaran, Vijaya https://orcid.org/0000-0002-0984-9938
Petlura, Christina
Bazouzi, Tamara
Josan, Kiranbir
Grewal, Upinder
Viethen, Thomas https://orcid.org/0000-0002-5334-1197
Mundl, Hardi
Luithle, Joachim
Basobas, Leonard
Touros, Alexis
Senior, Michael J. T. https://orcid.org/0000-0002-9064-7769
De Lombaert, Koen
Mahaffey, Kenneth W.
Turakhia, Mintu P. https://orcid.org/0000-0001-8025-0904
Dash, Rajesh
-
Funding
Funding for this research was provided by:
Bayer AG
- License Information
-
More Information
Article History
Received: 23 December 2021
Accepted: 19 May 2022
First Online: 28 June 2022
Competing interests
: A.S. reports research support from the American Heart Association. U.G., T.V., H.M., and J.L. are employees of Bayer A.G. M.J.T.S. is an employee of Huma Therapeutics Ltd. K.D.L. is an employee of Yuzu Labs PBC. K.W.M.’s financial disclosures can be viewed at . M.P.T. reports receiving research support from Janssen Inc., American Heart Association, Bristol Myers Squibb, Bristol Myers Squibb- Pfizer Alliance, Bayer, Apple, Boehringer-Ingelheim, AstraZeneca, and the National Institutes of Health; reports data use agreements for research with Medtronic and iRhythm; has received consulting fees from Abbott, Cardiva Medical, Medtronic, Johnson & Johnson, and Biotronik; has unexercised equity options in AliveCor Inc; and is an Associate Editor for JAMA Cardiology, Co-Chair of the Heart Rhythm Society Digital Health Subcommittee, and on the Editorial Board of Cardiovascular Digital Health Journal. R.D. reports equity from HealthPals, Heartbeam, and iMedrix; and consulting with Bayer and AstraZeneca. The remaining authors declare no competing interests.
